# Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome

> **NCT01857843** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 160 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** Zotalolimus Eluting Stent
- **DEVICE:** Everolimus eluting stent
- **DRUG:** Ezetimibe 10mg & Simvastatin 40mg
- **DRUG:** Pravastatin 20mg

## Key facts

- **NCT ID:** NCT01857843
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2013-11
- **Final completion:** 2014-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857843, "Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01857843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*